- 1.
Wu, K.; Ruan, C. Acupuncture for Chronic Obstructive Pulmonary Disease: A 38-Year Bibliometric Landscape of Global Research Trends and Knowledge Evolution (1986–2024). Int. J. Chron. Obstruct. Pulmon. Dis. 2025, 20, 2393–2408.
- 2.
Lepcha, I.; Patra, B.; Saha, D. Medicinal Plants in Ayurveda and Unani Systems including Siddha in the Indian Scenario; Shashwat Publication: Bilaspur, India, 2023.
- 3.
Wang, H.; Chen, Y.; Wang, L.; et al. Advancing herbal medicine: Enhancing product quality and safety through robust quality control practices. Front. Pharmacol. 2023, 14, 1265178.
- 4.
Ekar, T.; Kreft, S. Common risks of adulterated and mislabeled herbal preparations. Food Chem. Toxicol. 2019, 123, 288–297.
- 5.
Ichim, M.C. The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration. Front. Pharmacol. 2019, 10, 1227.
- 6.
Mohite, P.; Puri, A. Adulteration and evaluation of crude drugs of natural origin. In Pharmacognosy and Phytochemistry: Principles, Techniques, and Clinical Applications, 1st ed.; Willey: Hoboken, NJ, USA, 2025; pp. 101–121.
- 7.
Saggar, S.; Mir, P.A.; Kumar, N.; et al. Traditional and herbal medicines: Opportunities and challenges. Pharmacog. Res. 2022, 14, 107–114.
- 8.
Balkrishna, A.; Sharma, N.; Srivastava, D.; et al. Exploring the safety, efficacy, and bioactivity of herbal medicines: Bridging traditional wisdom and modern science in healthcare. Future Integr. Med. 2024, 3, 35–49.
- 9.
Acharya, R.; Narayanan, R.V.; Mahajon, B.; et al. Contributions to research and development by Central Council for Research in Ayurvedic Sciences (CCRAS): An appraisal. Int. J. Res. 2022, 3, 86–101.
- 10.
Alswaidi, F.M.; Abualssayl, A.A. Ayurveda; safety, effectiveness, and acceptance around the world. F1000Research 2025, 14, 62.
- 11.
Verma, S.K.; Pandey, M.; Sharma, A.; et al. Exploring Ayurveda: Principles and their application in modern medicine. Bull. Natl. Res. Centre 2024, 48, 77.
- 12.
Pugalenthi, M.; Deepa, M.A.; Pradheeba, M.; et al. An Insight to Intensify the Potential Prospects of Underutilized Wild Species of Piper. In Pomotherapeutic Insights on Wild Edible Fruits; Springer Nature Singapore: Singapore, 2025; pp. 89–113.
- 13.
Patil, P.; Gupta, M.; Semwal, A.; et al. Reviewing Bioenhancers in Traditional Indian Medicine: Exploring their Potential Mechanisms and Applications. Front. Health Infor. 2024, 13, 256.
- 14.
Haq, I.U.; Imran, M.; Nadeem, M.; et al. Piperine: A review of its biological effects. Phytother. Res. 2021, 35, 680–700.
- 15.
Singh, S.; Shukla, A. Therapeutic potential of piperine: A comprehensive review. Nat. Prod. Jour. 2024, 14, 53–67.
- 16.
Variyar, P.S.; Singh, I.P.; Adiani, V.; et al. Peppers: Biological, Health, and Postharvest Perspectives; CRC Press: Boca Raton, FL, USA, 2024.
- 17.
Ibrahim, M.; Detroja, A.; Sheth, B.P.; et al. Existing status and future advancements of adulteration detection techniques in herbal products. Mol. Bio. Rep. 2024, 51, 151.
- 18.
Paul, T.; Kumar, K.J. Standardization of herbal medicines for lifestyle diseases. In Role of Herbal Medicines: Management of Lifestyle Diseases; Springer Nature: Singapore, 2024; pp. 545–557.
- 19.
Takooree, H.; Aumeeruddy, M.Z.; Rengasamy, K.R.; et al. A systematic review on black pepper (Piper nigrum L.): From folk uses to pharmacological applications. Crit. Rev. Food Sci. Nutr. 2019, 59, S210–S243.
- 20.
Ayurvedic Pharmacopoeia Committee. The Ayurvedic Formulary of India; Controller of Publications: Delhi, India, 2003.
- 21.
Joshi, V.K.; Joshi, A.; Dhiman, K.S. The Ayurvedic Pharmacopoeia of India, development and perspectives. J. Ethnopharm. 2017, 197, 32–38.
- 22.
The Ayurvedic Pharmacopoeia of India. Available online: http://www.ayurveda.hu/api/API-Vol-3.pdf (accessed on 16 May 2024).
- 23.
Department of Ayurveda. Thin Layer Chromatographic (TLC) Atlas of Ayurvedic Pharmacopoeial Drugs, 1st ed.; Part I, Volume I; Department of Ayurveda: New Delhi, India, 2016.
- 24.
Khan, Z.R.; Moni, F.; Sharmin, S.; et al. Isolation of bulk amount of piperine as active pharmaceutical ingredient (API) from black pepper and white pepper (Piper nigrum L.). Pharmacol. Pharm. 2017, 8, 253–262.
- 25.
Parihar, A.K.S.; Sahu, U.; Karbhal, K.S.; et al. Quality Control of Triphala Churna. J. Med. Nat. Prod. 2024, 1, 100003.
- 26.
Sahu, U.; Chauhan, N.S.; Parihar, A.K.S.; et al. Development of Simultaneous HPTLC Method and Validation for the Quality Assessment of Ayurvedic Formulation—Ayush Kvatha Churna by Using Marker Compound Rosmarinic Acid, Trans-Cinnamaldehyde and Piperine. J. Chromatogr. Sci. 2025, 63, bmae019.
- 27.
Patel, S.; Baghel, G.S.; Chauhan, N.S.; et al. High-performance thin-layer chromatographic standardization and quantification of marker compounds in an Ayurvedic polyherbal formulation: Krishnadi Churna. JPC––Modern TLC 2021, 34, 493–502.
- 28.
Parihar, A.K.; Sahu, U.; Karbhal, K.S.; et al. Green HPTLC-method to estimate trans-Cinnamaldehyde in Ayurvedic formulation Sitopaladi Churna. TMMM 2023, 6, 1–8.